BLVRB and cancer: While HSF4 is known to be oncogenic in several cancer types, such as colorectal cancer, hepatocellular carcinoma, and lymphoma [55,56,57], our data suggested that HSF-dependent expression of SCAN-TFs could actually reduce oncogenic gene expression in tumors.